FOXA1 can bind to the promoters of more than 100 genes to influence signaling pathways and cell cycle in human cancers [18], while its specific mechanism in CRC cells resistant to radiotherapy remains largely unknown. This evidence concerns the gene FOXA1 and colorectal carcinoma.